AUS
NZ
UK
CA
USA
IND
Healt
GLH Selected As Preferred Client Information Management System Supplier For Sunraysia
March 26, 2019 03:46 PM AEDT| By Team Kalkine MediaGlobal Health Limited (ASX: GLH) develops and markets computer software. The Company offers software to the healthcare industry that enables the sharing of information. The company, today on 26 March 2019, has reported that it has been selected as t...
Uscom now authorised to sell its Type II Medical Devices directly in China
March 25, 2019 09:07 PM AEDT| By Team Kalkine MediaUscom Limited gets a green card for the sale of Type II Medical Devices in China through its wholly owned subsidiary company Uscom China. On Monday, 25 March 2019, Uscom Limited (ASX: UCM) announced that it has been granted a Type II Medical Device...
THC Global Group’s Securities Put on Trading Halt
March 25, 2019 09:02 PM AEDT| By Team Kalkine MediaTHC Global Group Limited (ASX: THC) operates in the pharmaceutical business. The company is primarily focused on developing cannabis. ?Also, the company focuses on the manufacturing and distribution of hydroponics equipment and nutrients. THC Global...
OncoSil Medical Receives The Recommendation From BSI; Stock Price Dives 69.38%
March 25, 2019 08:04 PM AEDT| By Team Kalkine MediaOncoSil Medical Limited (ASX: OSL), based in North Sydney, Australia is a medical device company engaged in advancing breakthrough treatments for pancreatic and liver cancer. Its flagship product is OncoSil, a targeted radioactive isotope (Phosphorou...
What is new about 2 healthcare stocks: HSO, MSB?
March 25, 2019 07:40 PM AEDT| By Team Kalkine MediaA leading private healthcare provider across Australia, Healthscope Limited (ASX: HSO) has updated the market about multiple ownership changes on 25 March 2019. The company has announced about the change of interests in its substantial holder, North...
Mesoblast’s licensee JCR Pharmaceuticals files for TEMCELL marketing approval
March 25, 2019 06:18 PM AEDT| By Team Kalkine MediaThe Melbourne, Australia-based Mesoblast Limited (ASX: MSB) is a bio-pharmaceutical company developing? proprietary allogeneic cellular medicines with a strong emerging pipeline of products. Today, the company announced that its Japan-based licensee...
REVA Medical secures $3 million debt facility, continues the voluntary suspension of trading
March 25, 2019 04:36 PM AEDT| By Team Kalkine MediaMedical Device company, REVA Medical, Inc. (ASX: RVA) remains voluntarily suspended on the Australian Securities Exchange as it seeks to finalise the funding requirement and future plan of the company. REVA has today announced the receipt of interim...
SomnoMed’s Core Business Earnings to be impacted by the Closing of its Major Customer -Simple Sleep Services
March 25, 2019 01:13 PM AEDT| By Team Kalkine MediaSomnoMed Limited (ASX: SOM) is a healthcare company which is primarily involved in providing diagnostic and treatment solutions for Sleep-related Breathing Disorders. In a trading update provided on 25 March 2019, the company admitted that its busin...
3 Healthcare Stocks on ASX - IMU, BTC, BIT
March 24, 2019 09:35 AM AEDT| By Team Kalkine MediaThe below mentioned health care stocks have reported loss for six months ended 31 December 2019. Let?s take a closer look at these stocks- Imugene Limited (ASX: IMU) The biotechnology company, Imugene Limited (ASX: IMU) recently disclosed that it...
Are These 2 Healthcare Stocks In Defensive Domain - API And RHC?
March 24, 2019 08:45 AM AEDT| By Team Kalkine MediaAustralian Pharmaceutical Industries Ltd Merger Called Off: Australian Pharmaceutical Industries Ltd?s (ASX: API) merger was called off by Sigma Healthcare. Sigma had got from API the non-binding proposal for the acquisition of all Sigma shares. Acc...
Are These 2 Biotech Stocks Too Hot To Be Looked At – BGT And TLX
March 23, 2019 10:00 AM AEDT| By Team Kalkine MediaThe Biotech companies have shown tremendous growth in the Australian markets in the past decades or so. Many of the start-ups in this field are also witnessing phenomenal drive and performing well. Let us now have a close look at two of the hot biote...
Factor Therapeutics Receives A Tax Rebate Of $2.488 Million
March 22, 2019 09:39 PM AEDT| By Team Kalkine MediaThe biotech company, Factor Therapeutics Limited (ASX: FTT) receives the tax incentive refund with respect to the eligible Research and Development expenditures incurred during the year 2018. In today?s announcement to Australian Securities Exchange...
Pharmaust Ltd Gets 66 Percent Subscription For Its Rights Issue, Raises $1.3 Million
March 22, 2019 07:17 PM AEDT| By Team Kalkine MediaA clinical stage oncology company, Pharmaust Limited (ASX: PAA) had on 26 February 2019 published its rights issue offer document. The company had intended to raise up to $2 million via the rights issue. The offer was scheduled to close on 19 March 2...
MedAdvisor releases investor presentation; signs agreement with US-based Adheris Health
March 22, 2019 06:46 PM AEDT| By Team Kalkine MediaThe Camberwell-based Medadvisor Limited (ASX: MDR) develops and offers medication management software in Australia. Its products include MedAdvisor medication and adherence platform, PlusOne end-to-end workflow management platform and Health Services...
Immutep Granted US Patent For IMP321
March 22, 2019 06:41 PM AEDT| By Team Kalkine MediaImmutep Limited (ASX: IMM) operates into the field of biotechnology. The Company emphasises on developing innovative immunotherapy to diagnose & treat for cancer and autoimmune disease. The company, today on 22 March 2019, has come out with an u...
CSL Limited Soars On ASX, Touches Its 2-Weeks' High!
March 22, 2019 06:08 PM AEDT| By Team Kalkine MediaBiotherapeutics company, CSL Limited (ASX: CSL) joins the upward trajectory on the Australian Securities Exchange with the stock price trading towards its two-week high levels. Today, 22 March 2019, the stock price surged up by 1.524% in line with t...
A Quick Look At Next Science’s Proprietary Technology
March 22, 2019 04:37 PM AEDT| By Team Kalkine MediaAustralian biotechnology company, Next Science Limited (Proposed ASX Code: NXS) provides next-level solutions for the treatment of biofilm and planktonic bacteria. Biofilm bacteria are extremely difficult to kill, and they account for nearly 80% of g...
Sigma Healthcare announced full-year results
March 22, 2019 03:23 PM AEDT| By Team Kalkine MediaAustralia?s Pharmacy wholesaler, Sigma Healthcare Limited (ASX: SIG) has announced its full-year results for the year ended 31st January 2019. The company marked a decline in sales revenue and reported the underlying sales revenue of $3976.8 million...
Cann Group released its investors' presentation: Stock zoomed up by 9.95%
March 21, 2019 10:56 PM AEDT| By Team Kalkine MediaCann Group Limited (ASX: CAN) is in the business of legal cannabis production and sales for medical purpose and is making an effort to tap the medical cannabis market. The first medicinal cannabis cultivation licence and medicinal cannabis research l...
Compumedics’ Shares arrowed up on signing a supply agreement with US-based Adventist
March 21, 2019 10:50 PM AEDT| By Team Kalkine MediaCompumedics Limited (ASX: CMP) ?is a medical device company which manufactures, develops and commercialises technology in regard to the diagnosis monitoring applications for the sleep, brain and ultrasonic blood-flow. The company has global footprint...
Advertise your brand on Kalkine Media